Globe Life Inc. (NYSE:GL) is included among the The 10 Most Profitable Undervalued Stocks to Buy
On February 6, 2026, JPMorgan analyst Jimmy Bhullar raised his price target on Globe Life Inc. (NYSE:GL) to $181 from $180 and reiterated an Overweight rating. The modest adjustment came following the company’s latest earnings update and the company’s fiscal 2026 earnings outlook.
A day earlier, on February 5, 2026, Globe Life Inc. (NYSE:GL) reported fourth-quarter revenue of $1.52 billion, slightly below the consensus estimate of $1.53 billion. While revenue was slightly below consensus expectations, investors’ attention was more focused on the company’s future prospects. For fiscal 2026, Globe Life Inc. (NYSE:GL) expects earnings between $14.95 and $15.65 per share, compared to a consensus estimate of $15.03. The range suggests management sees room for continued earnings growth.
Globe Life Inc. (NYSE:GL) offers supplemental life and health insurance products primarily to low- and middle-income households in the United States. Through its subsidiaries, the company operates in life insurance, supplemental health insurance and investments, offering a combination of whole life and term policies along with supplemental and limited-benefit Medicare health products, such as accident, cancer and critical illness coverage.
While we recognize GL’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: The 10 Most Profitable Undervalued Stocks to Buy and The 12 Best Nuclear Energy Stocks to Buy Now
Disclosure: None.